TRIER PHARM ApS: Financial statements 2014
CVR: 31611083
Source: annual report 2014, Danish Business Authority
01/01/2014 – 31/12/2014
TRIER PHARM ApS (CVR 31611083) has filed annual accounts for 2014. In 2014, the company reported revenue of DKK 387,000 and a net result of DKK -285,259 compared with DKK -21,476 the year before. That is an increase of 48.4% compared with the year before. The profit margin was -73.7%. Equity in the 2014 report amounted to DKK 470,879. The solvency ratio was 34.6%.
- Revenue
- DKK 387,000
- Gross Profit
- DKK -271,518
- Profit/Loss
- DKK -285,259
- Equity
- DKK 470,879
- Total Assets
- DKK 1,361,847
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2014 | 387 t. | -272 t. | -285 t. | 471 t. | - |
| 2013 | 261 t. | -17 t. | -21 t. | 756 t. | - |
| 2012 | 177 t. | 53 t. | 43 t. | 778 t. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2014
TRIER PHARM ApS has published its annual report for 2013. Revenue came to DKK 260,750, and the net result was DKK -21,476.
About TRIER PHARM ApS
TRIER PHARM ApS is a Danish company of the type Anpartsselskab based in Hellerup, founded in 2008. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Klaus Trier. The company is owned by KLAUS TRIER HOLDING ApS. According to the 2025 annual report, the company had an average of 1 employee. In 2025, the company reported a gross profit of DKK -37,612 and a net result of DKK -67,143 compared with DKK -18,582 the year before. Equity in the 2025 report amounted to DKK -632,769.